In Vivo Effects of Interleukin-10 on Contact Hypersensitivity and Delayed-Type Hypersensitivity Reactions
- 1 August 1994
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 103 (2), 211-216
- https://doi.org/10.1111/1523-1747.ep12393073
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Interleukin‐4 and interleukin‐10 synergize to inhibit cell‐mediated immunity in vivoEuropean Journal of Immunology, 1993
- Pentoxifylline Suppresses Irritant and Contact Hypersensitivity ReactionsJournal of Investigative Dermatology, 1993
- Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.The Journal of Experimental Medicine, 1993
- Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection.The Journal of Experimental Medicine, 1992
- Biological properties of interleukin 10Immunology Today, 1992
- Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.The Journal of Experimental Medicine, 1991
- Cultured Epidermal Langerhans Cells Activate Effector T Cells for Contact SensitivityJournal of Investigative Dermatology, 1990
- Homology of Cytokine Synthesis Inhibitory Factor (IL-10) to the Epstein-Barr Virus Gene BCRFIScience, 1990
- Studies on the Mechanism of Systemic Suppression of Contact Hypersensitivity by UVB Radiation. II. Differences in the Suppression of Delayed and Contact Hypersensitivity in MiceJournal of Investigative Dermatology, 1986
- IMPAIRMENT OF ANTIGEN-PRESENTING CELL FUNCTION BY ULTRAVIOLET RADIATION II. EFFECT OF IN VITRO ULTRAVIOLET IRRADIATION ON ANTIGEN-PRESENTING CELLSTransplantation, 1981